Holocene Advisors, LP
Source: SEC Form 13F · as of Mar 2026Holocene Advisors, LP holds 21 biotech & pharma companies tracked by BioSniper, totaling $1.71B in value as of Mar 2026 (SEC Form 13F).
Companies held
21
Total value held
$1.71B
BioSniper AIPage evidence connected
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 2,611,826 | $364.0M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 5,518,433 | $304.6M |
| RVMDREVOLUTION MEDICINES, INC. | 2,468,644 | $240.1M |
| TERNTerns Pharmaceuticals, Inc. | 4,115,828 | $217.0M |
| JAZZJazz Pharmaceuticals plc | 733,905 | $138.7M |
| SRRKScholar Rock Holding Corp | 1,890,927 | $93.0M |
| COGTCogent Biosciences, Inc. | 2,250,196 | $86.6M |
| TNGXTango Therapeutics, Inc. | 3,932,603 | $82.3M |
| DNLIDenali Therapeutics Inc. | 3,195,429 | $61.4M |
| ABVXAbivax SA | 258,657 | $28.8M |
| PTGXProtagonist Therapeutics, Inc | 209,916 | $22.1M |
| DFTXDefinium Therapeutics Inc. | 1,091,967 | $20.6M |
| MLTXMoonLake Immunotherapeutics | 600,000 | $11.2M |
| ORKAOruka Therapeutics, Inc. | 185,513 | $9.1M |
| GPCRStructure Therapeutics Inc. | 159,009 | $7.7M |
| CNTACentessa Pharmaceuticals plc | 160,942 | $6.4M |
| TEVATeva Pharmaceutical Industries Limited | 180,849 | $5.4M |
| APGEApogee Therapeutics, Inc. | 57,473 | $4.8M |
| MAZEMaze Therapeutics, Inc. | 136,168 | $4.1M |
| INCYIncyte Corp. | 7,662 | $721K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 11,679 | $660K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.